COMPARISON OF HUMAN TENASCIN EXPRESSION IN NORMAL, SIMIAN-VIRUS-40-TRANSFORMED AND TUMOR-DERIVED CELL-LINES

被引:36
作者
CARNEMOLLA, B [1 ]
BORSI, L [1 ]
BANNIKOV, G [1 ]
TROYANOVSKY, S [1 ]
ZARDI, L [1 ]
机构
[1] IST NAZL RIC CANC, CELL BIOL LAB, VIALE BENEDETTO XV 10, I-16132 GENOA, ITALY
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1992年 / 205卷 / 02期
关键词
D O I
10.1111/j.1432-1033.1992.tb16813.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tenascin is a polymorphic high-molecular-mass extracellular-matrix glycoprotein composed of six similar subunits. Using two-domain-specific anti-tenascin monoclonal antibodies, we have studied the expression and distribution of tenascin in four cultured normal human fibroblasts, two simian-virus-40-(SV40)-transformed and three tumor-derived (melanoma, rhabdomyosarcoma and fibrosarcoma) cell lines. We found that (a) cultured normal human fibroblasts accumulate considerable amounts of tenascin and retain 60-90% in the extracellular matrix, while they release the remainder into the tissue-culture medium; (b) of the two SV40-transformed counterparts we have tested, the AG-280 cell line accumulates no detectable amounts of tenascin and the WI-38-VA cell line accumulates about 10-times less tenascin than its normal counterpart and releases about 90% of it into the culture medium; (c) some tumor-derived cell lines accumulate considerable amounts of tenascin, but in theses cases, more than 90% is released into the culture media; (d) in normal human fibroblasts, two major tenascin isoforms, generated by alternative splicing of the mRNA precursor, are detectable (280 kDa and 190 kDa, respectively) and the lower-molecular-mass tenascin isoform is accumulated preferentially in the extracellular matrix; (e) in SV40-transformed or tumor-derived cell lines, only the higher-molecular-mass isoform is detectable and it is more sialylated than the tenascin produced by the normal human fibroblast cell lines.
引用
收藏
页码:561 / 567
页数:7
相关论文
共 57 条
  • [11] Stem Cells for Neonatal Brain Disorders
    Ahn, So Yoon
    Chang, Yun Sil
    Park, Won Soon
    [J]. NEONATOLOGY, 2016, 109 (04) : 377 - 383
  • [12] WHAT DISTINGUISHES TENASCIN FROM FIBRONECTIN
    CHIQUETEHRISMANN, R
    [J]. FASEB JOURNAL, 1990, 4 (09) : 2598 - 2604
  • [13] TENASCIN - AN EXTRACELLULAR-MATRIX PROTEIN INVOLVED IN TISSUE INTERACTIONS DURING FETAL DEVELOPMENT AND ONCOGENESIS
    CHIQUETEHRISMANN, R
    MACKIE, EJ
    PEARSON, CA
    SAKAKURA, T
    [J]. CELL, 1986, 47 (01) : 131 - 139
  • [14] CHIQUETEHRISMANN R, 1989, CANCER RES, V49, P4322
  • [15] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [16] SITE-RESTRICTED EXPRESSION OF CYTOTACTIN DURING DEVELOPMENT OF THE CHICKEN-EMBRYO
    CROSSIN, KL
    HOFFMAN, S
    GRUMET, M
    THIERY, JP
    EDELMAN, GM
    [J]. JOURNAL OF CELL BIOLOGY, 1986, 102 (05) : 1917 - 1930
  • [17] DAVIS LG, 1986, BASIC METHODS MOL BI, P143
  • [18] EKBLOM P, 1989, International Journal of Developmental Biology, V33, P71
  • [19] A 6-ARMED OLIGOMER ISOLATED FROM CELL-SURFACE FIBRONECTIN PREPARATIONS
    ERICKSON, HP
    INGLESIAS, JL
    [J]. NATURE, 1984, 311 (5983) : 267 - 269
  • [20] TENASCIN - AN EXTRACELLULAR-MATRIX PROTEIN PROMINENT IN SPECIALIZED EMBRYONIC-TISSUES AND TUMORS
    ERICKSON, HP
    BOURDON, MA
    [J]. ANNUAL REVIEW OF CELL BIOLOGY, 1989, 5 : 71 - 92